Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-755 in cTTP Continuation Study
NCT04683003Phase 3Active, not recruiting
- Sponsor
- Takeda
- Start
- Apr 2021
- Primary completion
- Mar 2027
- Modality
- Replacement Enzymes
- Countries
- 11
01
Overview
A Phase 3 trial of Apadamtase alfa in thrombotic thrombocytopenic purpura (TTP), sponsored by Takeda. Started Apr 2021; status: active, not recruiting.
02
Drugs
Apadamtase alfa
03
Conditions
thrombotic thrombocytopenic purpura (TTP)
Beyond the preview
Go deeper on NCT04683003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04683003.